ScholarWorks@Korea University College of Medicine: Ham, Byung Joo

Detailed Information

Ham, Byung Joo (함병주)

Anam Hospital (Department of Psychiatry, Anam Hospital)

Research Area: 기분장애, 신경영상학, 정신약물학, Mood disorder, Neuroimaging, Psychopharmacology

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Major depressive disorder:35||Depression:29||major depressive disorder:12||Cortical thickness:11||depression:10||Magnetic resonance imaging:9||Antidepressant:7||polymorphism:6||Bipolar disorder:6||Polymorphism:6||Voxelbased morphometry:6||Prefrontal cortex:6||Hippocampus:5||Suicidal ideation:5||Functional magnetic resonance imaging:5||schizophrenia:4||Treatment response:4||Anterior cingulate cortex:4||Gray matter:4||DNA methylation:4||Alexithymia:4||5HTTLPR:3||Anger:3||Genetic polymorphism:3||anger:3||Neuroinflammation:3||Amygdala:3||local gyrification index:3||treatment response:3||Panic disorder:3||Diffusion tensor imaging:3||Mirtazapine:3||우울증:3||mirtazapine:3||Treatment outcome:3||Antidepressants:2||Imaging genetics:2||antidepressant:2||White matter:2||Voxelbased morphometry (VBM):2||stress:2||Inflammation:2||Surface area:2||efficacy:2||Medicationnaive:2||Latelife depression:2||Functional magnetic resonance imaging (fMRI):2||Tryptophan hydroxylase 2:2||Elderly:2||tolerability:2||Moderator:2||tryptophan hydroxylase:2||Orbitofrontal cortex:2||Cortical volume:2||Hippocampal subfield volume:2||Mood disorders:2||magnetic resonance imaging:2||major depression:2||Ventrolateral prefrontal cortex:2||Sexual abuse:2||carbohydratedeficient transferrin:2||cortical folding:2||Parahippocampal cingulum:2||cortical thickness:2||항우울제:2||Schizophrenia:2||Particulate matter:2||neuroimaging:2||Workers:2||Alcohol dependence:2||functional magnetic resonance imaging (fMRI):2||sad:2||Machine learning:2||Women:2||Wholeexome sequencing:2||Uncinate fasciculus:2||Magnetic resonance spectroscopy:2||fMRI:2||deep learning:2||Gender:2||Depressive disorder:1||Depressive disorders:1||Depressive mood:1||Depressive symptoms:1||Diagnostic utility:1||Diffusion tensor image:1||Diffusion tensor imaging (DTI):1||Dopamine receptor D2:1||Dopamine receptor D2TaqI A polymorphism:1||Dorsal raphe nuclei:1||Dorsomedial prefrontal cortex:1||ELISA:1||ERK phosphorylation:1||EWAS:1||Early diagnosis:1||Education:1||Efficacy:1||Emotion:1||Emotion regulation:1||Emotional social support:1||Emotional valence and arousal manikin·Selfassessment manikin·Emotion.:1||Empathy:1||Employees:1||Epigenetic regulation:1||Epigenetics:1||Escitalopram:1||Escitalopram treatment response:1||Executive function:1||FAM19A5:1||FKBP5:1||Facial expression:1||Facial stimuli:1||Factor analysis:1||Fear:1||First episode:1||Firstepisode:1||FreeSurfer:1||GPCR dimerization:1||Gammaaminobutyric acid:1||Gene:1||Geneenvironment interaction:1||Generic:1||Geriatric depression·Early onset depression·Late onset depression.:1||Gray matter abnormalities:1||Guideline:1||Handgrip strength:1||Health care utilization:1||Highsensitivity Creactive protein:1||HwaByung:1||Hycanthone:1||ITAC:1||IAPS:1||IL17:1||IL23:1||IP10:1||Imaging genetic study:1||Imaging genetics studies:1||Immune:1||Immune responses:1||Impulsivity:1||Income:1||Individual differences:1||Inferior longitudinal fasciculus:1||Inflammatory cytokines:1||Initial choice:1||Inpatient:1||Interferon signaling:1||Intimate partner violence:1||Irritable bowel syndrome· Peptic ulcer disease· Temperament· Character· Stress response· Harm avoidance.:1||KMT2C:1||Korea:1||Korea National Health and Nutrition Examination Survey:1||Korean.:1||LCSPT circuits:1||LPS:1||Life stress:1||Lingual gyrus:1||Long insula.:1||Longitudinal:1||Longitudinal study:1||MCP1:1||MIG:1||MRI:1||Magnetic resonance imaging (MRI):1||Major Depressive Disorder (MDD):1||Major depressive disorders:1||MeCP2:1||Medical comorbidity:1||Mental disorders:1||Mental health:1||Mental health service:1||Metabolic syndrome:1||Methylation:1||Microstructure:1||Midbrain:1||Mild cognitive impairment:1||Mirtazapine treatment response:1||Monoamine oxidase A:1||Monoamine oxidase Aupstream variable number of tandem repeats:1||Monoaminergic genes:1||NFKB:1||NLRP3:1||NMDA receptor:1||NR2B:1||NanoBiT assay:1||NanoBiT technology:1||Negative:1||Negative modulation:1||Neighborhood condition:1||Nerve growth factor:1||Network analysis:1||Neural circuit:1||Neuroimaging:1||Neurokinin receptors:1||Neurotrophin:1||Nitrogen:1||North Korean refugees:1||Nucleus accumbens:1||Obesity:1||Occipital cortex.:1||Openlabel study:1||Orbitofrontal cortex thickness:1||Oxytocin:1||PAM:1||Paliperidone ER:1||Paroxetine hydrochloride:1||Paroxetine mesylate:1||Perceived stigma.:1||Perceptionaction model:1||Perpetration:1||Personality traits:1||Personality traits.:1||Pharmacological Treatment:1||Pharmacological treatment:1||Pharmacotherapy:1||Physical activity:1||Physical illness:1||Plasma:1||Polypharmacy:1||Pons:1||Positive:1||Posttraumatic stress disorder:1||Posttraumatic stress disorder:1||Posttraumatic stress disorder (PTSD):1||Posttraumatic stress disorder·Temperament and character inventory·Burn.:1||Precarious employment:1||Precision psychiatry:1||Prefrontal dysfunction:1||Probabilistic tractography:1||Proopiomelanocortin:1||Psychiatric diagnosis:1||RRBS:1||Randomizedcontrolled clinical trials:1||Reactive astrogliosis:1||Reliability:1||Resilience:1||Respiratory type:1||Restingstate functional connectivity:1||Reward circuit:1||Reward processing:1||Risk factors:1||SP8356:1||Sadness:1||Safety:1||Schizophrenia.:1||Selfrated health:1||Serotonergic:1||Serotonin 2C receptor:1||Serotonin 5A receptor:1||Serotonin transporter.:1||Social participation:1||Socioeconomic factor:1||Socioeconomic satisfaction:1||Socioeconomic status:1||Somatic symptom.:1||Sparse Group LASSO:1||Splice variant:1||Stess:1||Stress:1||Striatum:1||Subcortical region:1||Subcortical volume:1||Subregion:1||Subregion morphology:1||Substance P:1||Suicide:1||Suicide attempt:1||Sulcal depth:1||Superior longitudinal fasciculus:1||Superiority:1||Symptomfocused approach:1||Synaptic plasticity:1||TAS20:1||TBSS:1||TESC gene:1||TPH2 rs4570625:1||Tachykinin precursor 1 gene:1||Temperament and Character Inventory:1||Th17 cell:1||Thalamus:1||Tissue type plasminogen activator:1||Tolerability:1||Tolerability.:1||Transforming Growth Factor beta1:1||Trauma:1||Traumatic brain:1||Treatment:1||Tryptophan hydroxylase1:1||VMAT1:1||Validity:1||Vascular endothelial growth factor:1||Ventral pallidum:1||Ventromedial prefrontal cortex:1||Victimization:1||Vision transformer:1||Weight gain:1||White matter abnormalities:1||White matter connectivity:1||White matter tract integrity:1||Work hours:1||Workfamily conflict:1||Workplace gender discrimination:1||affective disorders:1||affective symptoms:1||age of onset:1||alcohol dependence:1||alternative pathway:1||angerrelated behavior:1||anterior cingulate cortex:1||anterior cingulate gyrus:1||antidepressant response prediction:1||antidepressant treatment:1||anxiety:1||appetite:1||aripiprazole:1||attitude:1||basal ganglia:1||betaArrestin:1||biological marker:1||body weight:1||brain age:1||brain magnetic resonance imaging:1||brainderived neurotrophic factor:1||calmodulin:1||chemotaxis:1||chest radiography:1||chocolate:1||citalopram:1||clinical trial:1||cognitive function:1||complement factor H:1||complement system:1||complexity:1||computeraided diagnosis (CAD):1||correlation:1||cost:1||cytosolic Ca2+ sensor:1||depressive disorder:1||diagnostic model:1||diffusiontensor imaging:1||diffusiontensor imaging scalar:1||dimensional complexity:1||drug response:1||duration of untreated depression:1||effective connectivity:1||elder:1||electroencephalography:1||endophenotype:1||epigenetics:1||estradiol:1||face:1||fatigue:1||fibromyalgia:1||firstepisode schizophrenia:1||food intake:1||functional connectivity:1||functional magnetic resonance imaging:1||galanin receptor 2 agonist:1||gammaGlutamyltransferase:1||gammaglutamyltransferase:1||gene polymorphisms:1||genes:1||genotype:1||geriatric depression:1||glucocorticoid:1||go:1||graph convolutional networks (GCNs):1||in vitro cell transformation assay:1||inflammation:1||information transmission:1||informed consent:1||interparental violence:1||internal ribosome entry site:1||intranasal administration:1||lateral asymmetry:1||local shape volume:1||lost productive time:1||lung diseases:1||machine learning:1||magnetic resonance image:1||major depressive disorder (MDD):1||mean corpuscular volume:1||menopause:1||mental health:1||mental health service:1||metaanalysis:1||methylation profiles:1||milnacipran:1||monoamine oxidase a gene:1||monoamine oxidaseA:1||mutual information:1||myosin light chainC kinase 1/2:1||negative priming task:1||nerve growth factor:1||neural network:1||neuroimagingepigenetic study:1||neuroinflammation:1||neurological disorders:1||neurotoxicity:1||newer antidepressants:1||nogo task:1||nongenotoxic carcinogen:1||norepinephrine transporter:1||offtarget:1||orbitofrontal cortex:1||pain:1||paroxetine:1||paroxetine safety:1||patient representation:1||personality:1||pharmacogenetic:1||posttraumatic stress disorder:1||postprocessing:1||posttraumatic stress disorder:1||prefrontal cortex:1||presenteeism:1||productivity:1||rTMS:1||restingstate functional magnetic resonance imaging (rsfMRI):1||reward:1||rs7294919:1||sMRI:1||sadness:1||selective serotonin reuptake inhibitor:1||selfconfidence:1||selfcontrol:1||selfrecognition:1||serotonin receptor 1A:1||serotonin transporter:1||sex hormones:1||simple fully convolutional networkbased regression:1||singlebase precision:1||sound and light stimuli:1||specificity:1||striatum:1||structural magnetic resonance imaging:1||suicidal ideation:1||suicidality:1||support vector regression:1||survey:1||thalamus:1||thyroid hormone:1||visual pathway:1||βarrestin:1||감정표현불능증:1||과민성 대장증후군·소화성궤양·기질·성격·스트레스반응·위험회피성.:1||기계 학습:1||내약성:1||노인 우울증·조발성 우울증·만발성 우울증:1||비정형 항정신병 약물:1||스트레스:1||신체질환:1||알코올 의존:1||약물 반응성:1||약물학적 치료:1||외상후 스트레스 장애·기질성격검사·화상.:1||우울 장애:1||자살:1||정서가 및 각성수준에 대한 자가 평가 마네킹· 자가 평가 마네킹·정서.:1||조현병:1||진단 모델:1||초기선택:1||탄수화물 결핍 트랜스페린:1||평균 적혈구 용적:1||한국형.:1||화소기반형태분석법:1||회백질:1||Arrestin 1:1||효과:1||ADRA1A R347C:1||Acute lung injury:1||Adaptation:1||Adjustment disorders:1||Adolescent:1||Adrenoreceptor alpha 1a:1||Adult worker:1||Affect:1||Agoraphobia:1||Alcohols:1||Alu insertion/deletion:1||Amyloid accumulation:1||Animal model:1||Anterior cingulate:1||Anterior corona radiata:1||Antidepressant responsiveness:1||Antidepressive agents:1||Antipsychotic agent:1||Anxiety:1||Anxiety (psychic):1||Aripiprazole:1||Astrocyte:1||Attempted suicide:1||Attention deficit:1||Attentional blink:1||Atypical antipsychotic:1||Atypical antipsychotics:1||Augmentation:1||BDNF Val66Met:1||BDNF Val66met polymorphism:1||Barratt Impulsiveness Scale:1||BclI C/G (rs41423247):1||Behavioral approach system:1||Biomarker:1||Bipolar I disorder:1||Bipolar subtype:1||Brain age:1||Brain connectome:1||Brain magnetic resonance imaging:1||Brain mapping:1||Brainderived neurotrophic factor:1||Brainderived neurotropluc factor (BDNF):1||Brainstem:1||Brandname product:1||Breast cancer:1||C4 binding protein:1||CCR2:1||CDH23:1||COMT:1||COVID19:1||CRISPR:1||CXCR3:1||CYP2D6:1||CYP2D6 polymorphism:1||Calcium signaling:1||CatecholamineOmethyl transferase:1||Caudate nucleus:1||Cell migration:1||Central sulcus:1||Centrality:1||Cerebellar volume:1||Cerebellum:1||Chemotaxis:1||Child adversity:1||Childhood abuse:1||Childhood adversity:1||Childhood trauma:1||Chronic disease:1||Cognitive function:1||Complement:1||Computer vision models:1||Concept:1||Cornu ammonis:1||Corticotropin releasing hormone:1||Cytokine:1||Cytokines:1||DLPFC:1||Dentate gyrus:1||Depression scale:1||

STATISTICS: Total View :13,965,807; Today View :13,755

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE